Search results
Results from the WOW.Com Content Network
German Center for Neurodegenerative Diseases (DZNE) – Helmholtz Centre; ... This page was last edited on 18 January 2025, at 23:46 (UTC).
The World Parkinson Congress, often referred to as the WPC, is a non-religious, non-political, and non-profit making organization concerned with the health and welfare of people living with Parkinson's disease (PD) and their families and caregivers. Founded in 2004, the WPC aims to bring the Parkinson's community together, under one roof, to ...
Justin John Yerbury AM (3 May 1974 – 28 July 2023) was an Australian molecular biologist who was spurred to follow a career in biological research when he discovered that his family has the genetic form of motor neurone disease (MND). He held the position of Professor in Neurodegenerative Disease at the University of Wollongong. He was ...
The institute is a biomedical discovery institute aiming to help understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections and neurodegenerative diseases. [35]
Alzheimer's disease (AD) is a chronic neurodegenerative disease that results in the loss of neurons and synapses in the cerebral cortex and certain subcortical structures, resulting in gross atrophy of the temporal lobe, parietal lobe, and parts of the frontal cortex and cingulate gyrus. [14] It is the most common neurodegenerative disease. [1]
Topics covered include neural stem cells, neural tissue engineering, gene therapy, and minimally-invasive treatment of neurodegenerative diseases. It was established in 2006 and the editors in chief are Kwok-Fai So (University of Hong Kong) and Xiao-Ming Xu (Indiana University). The journal publishes the following types of papers: research and ...
In September 2015, Prof Sarah Tabrizi began the first human trial of a 'gene silencing' antisense oligonucleotide drug, IONIS-HTT Rx, for the neurodegenerative disease Huntington's disease at the institute's Leonard Wolfson Experimental Neurology Centre. [22]
In 2020, researchers at The University of Texas Health Science Center at Houston concluded that protein misfolding cyclic amplification could be used to distinguish between two progressive neurodegenerative diseases, Parkinson's disease and multiple system atrophy, being the first process to give an objective diagnosis of Multiple System ...